ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Resolution of Endothelial Inflammation is Delayed Following IFNγ, Which Provokes a Long-lasting Pro-adhesive Phenotype Dependent on JAK/STAT Signaling

N. M. Valenzuela

Pathology and Laboratory Medicine, UCLA, Los Angeles, CA

Meeting: 2021 American Transplant Congress

Abstract number: 254

Keywords: Endothelial cells, Inflammation, Interferon (IFN), Jak/STAT

Topic: Basic Science » Endothelial Cell Biology

Session Information

Session Name: Rejection, Innate Immunity and Allorecognition

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 7, 2021

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:25pm-6:30pm

Location: Virtual

*Purpose: Although many cytokines are upregulated within allografts undergoing rejection, intragraft transcripts are dominated by IFN-response signatures. Resolution is a key phase of inflammation needed to reduce accumulation of immune cells at local sites, followed by restoration of normal function. Failure to attenuate this process leads to a detrimental, chronic response and maladaptive immunity that underlies many inflammatory diseases, including chronic allograft rejection. Blood endothelial cells (EC) actively regulate access of leukocytes to peripheral tissues and regulate egress in response to inflammatory insult. Much has been studied on the initiation of inflammation during endothelial activation, but less is known about the kinetics and mechanisms necessary for the return to a non-inflamed state.

*Methods: We examined the profile, kinetics and contraction of type II endothelial activation by NFκB-driven TNFα and JAK/STAT-mediated IFNγ. Endothelial pro-adhesive phenotypes were compared under chronic cytokine stimulation (1-48hr), and upon short-term cytokine priming (3hr) followed by withdrawal (up to 48hr). We tested HMEC-1 and primary human endothelial cells from 6 different vascular beds. Endothelial activation was measured at the mRNA and protein levels by Nanostring, flow cytometry, ELISA and multiplex Luminex assays. JAK1/2 was inhibited with ruxolitinib (20nM-2μM).

*Results: TNFα promoted early expression of E-selectin, VCAM-1, ICAM-1, and broad biphasic induction of chemokines. IFNγ upregulated ICAM-1, BST2 and a restricted set of CXCL chemokines. The dynamics of endothelial adhesive phenotype changes after withdrawal were also distinct. A small proportion of TNFα-induced endothelial phenotype changes persisted, but most other effects required continuous TNFα exposure for reinforcement. In contrast, the consequences of even short exposure (3hr) to IFNγ were long-lasting and broad, with sustained elevation of adhesion molecules and chemokines 48hr later. NFκB genes and target transcriptional changes were quickly down-regulated in the absence of TNFα, while JAK, STAT and IRF gene expression was durable, dependent on new transcription but independent of continuous IFNγ exposure. Finally, intact persistent JAK signaling in the endothelium was required to maintain a pro-adhesive phenotype after IFNγ withdrawal, which could be prevented by the JAK1/2 inhibitor ruxolitinib.

*Conclusions: Our results reveal a sustained perturbation of endothelial function and pro-adhesive phenotype after exposure to IFNγ, mediated by JAK and dependent on new transcription. The resolution of endothelial-controlled inflammation may therefore be impaired or delayed under JAK conditions, but quiescence more readily re-established when perturbation was dependent on NFκB. JAK antagonism may therefore represent a novel therapeutic approach to dampening intragraft inflammation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Valenzuela NM. Resolution of Endothelial Inflammation is Delayed Following IFNγ, Which Provokes a Long-lasting Pro-adhesive Phenotype Dependent on JAK/STAT Signaling [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/resolution-of-endothelial-inflammation-is-delayed-following-ifn%ce%b3-which-provokes-a-long-lasting-pro-adhesive-phenotype-dependent-on-jak-stat-signaling/. Accessed May 28, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences